The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 14th 2025
The announcement came shortly before updated results from the SURMOUNT-5 clinical trial, which found Zepbound had superior weight-loss effects over Wegovy.
Valeant Pharmaceuticals To Appoint Robert L. Rosiello As Chief Financial Officer
June 11th 2015Valeant Pharmaceuticals International, Inc. announced today that Robert L. Rosiello was appointed as Executive Vice President and will take over the role of Chief Financial Officer on July 1, 2015.
Read More